Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

  1. Grisham, R.N.
  2. Vergote, I.
  3. Banerjee, S.
  4. Drill, E.
  5. Kalbacher, E.
  6. Mirza, M.R.
  7. Romero, I.
  8. Vuylsteke, P.
  9. Coleman, R.L.
  10. Hilpert, F.
  11. Oza, A.M.
  12. Westermann, A.
  13. Oehler, M.K.
  14. Pignata, S.
  15. Aghajanian, C.
  16. Colombo, N.
  17. Cibula, D.
  18. Moore, K.N.
  19. del Campo, J.M.
  20. Berger, R.
  21. Marth, C.
  22. Sehouli, J.
  23. O’Malley, D.M.
  24. Churruca, C.
  25. Kristensen, G.
  26. Clamp, A.
  27. Farley, J.
  28. Iyer, G.
  29. Ray-Coquard, I.
  30. Monk, B.J.
  31. Montrer des auteurs +
Revue:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Année de publication: 2023

Volumen: 29

Número: 20

Pages: 4068-4075

Type: Article

DOI: 10.1158/1078-0432.CCR-23-0621 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus